From: Bench-to-bedside review: Inhaled nitric oxide therapy in adults
 |  |  |  | Intervention |  |  | |
---|---|---|---|---|---|---|---|
Study | Year | Number of patients/centres | Patient details | Control | Inhaled nitric oxide | Primary outcome | Secondary outcomes |
Dellinger, et al. [48] | 1998 | 177/30 | AECC ARDS within 72 hours. Excluded severe sepsis or non-pulmonary organ failure | Nitrogen | 1.25 to 80 ppm | Duration of MV | Oxygenation, PAP, and 28-day survival |
Michael, et al. [49] | 1998 | 40/1 | ARDS with PFR <150 mm Hg and CXR infiltrates | Usual care | 5, 10, 15, and 20 ppm every 6 hours for 24 hours, then clinically adjusted | Improvement in oxygenation to allow decrease in FiO2 | Persistence of improvements in oxygenation |
Troncy, et al. [50] | 1998 | 30/1 | Lung injury score ≥ 2.5 | Usual care | Initial titration (2.5, 5, 10, 20, 30, and 40 ppm every 10 minutes) and daily re-titration | Free from MV within 30 days | 30-day mortality and duration of MV |
Lundin, et al. [51] | 1999 | 268/43 | CXR infiltrates and ARDS with PFR <165 mm Hg with MV for 18 to 96 hours | Usual care | 2, 10, or 40 ppm (lowest effective dose) | Reversal of ALI | 30- and 90-day survival, ICU and hospital LOSs, and organ failure |
Gerlach, et al. [3] | 2003 | 40/1 | 0.6, AECC ARDS, FiO2 ≥ PFR 150 mm Hg, ≤ PEEP ≥ 10 cm H2O, and PAOP ≤ 18 mm Hg. Duration of ventilation ≥ 48 hours. | Usual care | 10 ppm (with daily dose-response analysis) | Dose-response relationship with PaO2 and iNO | Duration of ventilation and ICU LOS |
Park, et al. [52] | 2003 | 23/1 | AECC and duration of ARDS ≤ 2 days | Usual care | 5 ppm ± recruitment manoeuvres | Oxygenation | - |
Taylor, et al. [53] | 2004 | 385/46 | ARDS with PFR <250. Excluded sepsis as cause of ALI and any non-pulmonary organ failure. | Nitrogen | 5 ppm in 192 patients | Survival without need for MV during the first 28 days | Oxygenation and PEEP and 28-day survival |